Prevention of Nosocomial Bacteremia Among Zambian Neonates

NCT02386592 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9410

Last updated 2017-07-31

No results posted yet for this study

Summary

The purpose of this study is to estimate the burden of disease, identify risk factors associated with nosocomial bacteremia among neonates and assess the efficacy of low-cost measures targeted to known and suspected nosocomial BSI (bloodstream) risk factors, the investigators propose to study the impact of a novel package of infection control interventions on nosocomial bacteremia and mortality among neonates at a tertiary care center in sub-Saharan Africa.

Conditions

  • Neonatal Sepsis
  • Neonatal Mortality

Interventions

DRUG

Chlorhexidine gluconate (CHG)

All enrolled neonates admitted to the NICU during the implementation and intervention periods will undergo CHG bathing (sparing head and face) at the time of admission at and thereafter once weekly.

BEHAVIORAL

Hand hygiene (HH)

Alcohol hand rub will be produced in the hospital pharmacy and will be readily available in the NICU (via wall-mounted dispensers) throughout the intervention period. Hand hygiene among NICU physicians and nurses will actively be promoted through the intervention period.

BEHAVIORAL

Infection control training

All NICU healthcare workers will receive infection prevention training which will involve structure training on HH, universal precautions, neonatal skin antisepsis and peripheral IV placement and line care.

OTHER

Infection control reminders via SMS text

Infection control practice reminders will be sent to NICU healthcare workers on a daily basis via SMS messages.

Sponsors & Collaborators

  • University Teaching Hospital, Lusaka, Zambia

    collaborator OTHER
  • Zambia Center for Applied Health Research and Development

    collaborator OTHER
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • Boston University

    lead OTHER

Principal Investigators

  • Davidson H Hamer, MD · BU School of Medicine

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Hour
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2017-04-15
Completion
2017-07-31

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02386592 on ClinicalTrials.gov